Atlas Trials

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

Clinical trial NCT01471470 · COMPLETED

Trial details

NCT number
NCT01471470
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Gastric Cancer
Start date
2010-07-01
Primary completion
2017-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.